Drug recall · June 10, 2026
Amlodipine and Olmesartan Medoxomil Tablets recall
Why: Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
- Lots / codes
Lot: 24123460, Expires: October 31, 2027.
- Quantity
- 15,696 x 30's bottles
- Company
- Ascend Laboratories, LLC, Bedminster, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- May 5, 2026 · Voluntary: Firm initiated
- Classified
- June 2, 2026
- Reported
- June 10, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / olmesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.